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Introduction
 Many physiological functions are under both 
endocrine and nervous systems. The endocrine system is 
composed of glands that secrete hormones directly into 
the blood circulation to be carried towards distant target 
organs. In the nervous system, the hypothalamus is the 
control center of all autonomic regulatory activities and 
play a hub interconnected in brain regions including 
the brainstem, the limbic system, and the autonomous 
nervous system and also in endocrine organs. There is a 
bidirectional interaction between the endocrine organs 
and the central nervous system. The hypothalamus 
controls the function of the pituitary gland that is the 
master gland of the endocrine system. The pituitary 
gland is composed of anterior, intermediate, and 
posterior lobes. The posterior pituitary contains and 
releases two hormone, vasopressin and oxytocin which 
are synthesized in the hypothalamus. Vasopressin is 
an antidiuretic hormone, which retains water in the 
body and constricts blood vessels. The conventional 
function of oxytocin is contraction of the smooth muscle 
of the uterus and the milk ejection reﬂex for suckling. 
The anterior pituitary produces endocrine hormones 
containing adrenocorticotropic hormone (ACTH), 
thyroid-stimulating hormone (TSH), follicle-stimulating 
hormone (FSH) and luteinizing hormone (LH), growth 
hormone (GH), and prolactin (PRL). Their production and 
release into the blood are regulated by the hypothalamus. 
Each hormone regulates several physiological processes 
including stress, growth, reproduction and lactation in 
their target endocrine organs. The regulatory pathway 
from the hypothalamus to pituitary endocrine organs is 
known as hormone axis with each cascade manner. The 
timing of releasing the anterior pituitary hormones is 
adjusted to both the most favorable time in the normal 
physiological condition and the priority of hormone 
axis in abnormal events. The hypothalamic‒pituitary‒
gonadal axis (HPG axis) in the reproduction is most 
sensitive in various environments. Both a physical 
and emotional burden on women, for example, eating 
disorders, depression, anxiety, stress, physical exercise, 
energy availability and weight loss, are associated with 
markedly reduced secretion of the gonadotropins in the 
HPG axis(1). Increased cortisol secretion, which reﬂect 
increased endogenous CRH activity, has been noticed 
in eating disorders or after exercise in many women(2). 
In addition to HPA hormones, vasopressin released 
from the hypothalamic paraventricular nucleus (PVN) is 
known to increase ACTH secretion in synergistical action 
with CRH on the corticotrophs(3). This compensatory of 
increase may be eﬀective for the adaptation to repeated 
stress because the stress results a down-regulation of 
CRH gene expression in the PVN(4). In this case, HPA-HPG 
link is dependent on the hypothalamic functions. In the 
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relationship between fertility and energy homeostasis, 
studies show that severe dietary restriction, catabolic 
states and even short-term caloric deprivation impair 
fertility in mammals. Likewise, obesity is associated with 
infertile conditions such as polycystic ovary syndrome. 
These fertility involves the action of insulin and leptin in 
the hypothalamus(5). The activation of HPG axis involves 
several neuropeptides. For an example, kisspeptin 
activates gonadotropin releasing hormone neurons to 
increase the serum levels of luteinizing(6). In the same 
way, many reports refer to the modulation of the HPG 
axis in the hypothalamus. On the comparison, there is not 
so much reports about the intercellular communication 
in the anterior pituitary. A lot of factors that secreted 
within the anterior pituitary interact to synthesize and 
secrete the pituitary endocrine hormones. A broad 
survey of literature about the interaction within the 
anterior pituitary has been reviewed(7). Herein, we review 
the action of galanin and neuropeptide Y in the pituitary 
and propose the galanin hypothesis in the neuronal 
plasticity.
Galanin in the anterior pituitary
 Galanin is a peptide consisting of a chain of 29 
amino acids or 30 amino acids produced from the 
cleavage of a 123-amino acid length preprogalanin, 
which is encoded by the GAL gene. Galanin is located 
in the central and peripheral nervous systems and 
is colocalized with many neurotransmitters. Galanin 
is involved in the modulation of action potentials in 
neurotransmission. Action potentials are initiated by 
excitatory postsynaptic potentials from a presynaptic 
neuron where neurotransmitter molecules are released. 
While the neurotransmitters bind to their speciﬁc 
receptors on the postsynaptic cells, these binding open 
various types of ion channels. Galanin does not change 
the neurotransmitter binding but change the ion channel 
opening and/or signaling through G-protein-coupled 
neurotransmitter receptors.
 Galanin is localized within speciﬁc cell types of the rat 
anterior pituitary gland. Immunohistochemical studies 
show that lactotrophs(8), somatotrophs(9), corticotroph(10) 
and thyrotrophs(9) contain galanin in the intact female 
rat. Galanin is an estrogen-inducible peptide and its 
gene expressed in the anterior pituitary in the control 
of physiologic levels of circulating estrogen(11,12). Since 
the production and secretion of galanin in the anterior 
pituitary are stimulated by estrogen, the interaction 
between galanin and pituitary endocrines may be 
involved in the period of the exposure of estrogen in 
the homeostatsis. Estrogen is the primary female sex 
hormone which is responsible for the development 
and regulation of the female reproductive system. The 
release of estrogen is dependent on the estrus cycle 
of each vertebrate. The estrogen concentration in the 
circulation is the highest level in the proestrus state, 
wherein LH surge is stimulated. However, there is little 
knowledge of the direct interaction between galanin and 
the production of LH. Moreover, both galanin knockout 
and overexpressing mice show the failure of infertility 
phenotypes. Therefore, the present studies demonstrate 
no relationship between galanin and gonadtrophs in the 
pituitary.
Interaction between galanin and 
endocrine cells in the pituitary 
 In the consideration of the physiological actions, 
we should regard that estrogen in physiological and 
pharmacological doses produces a signiﬁcant increase 
in galanin content. Targeted disruption of the murine 
galanin gene shows that PRL mRNA levels and protein 
content of adult female were reduced by 30-40% 
compared with wild-type controls(13). Mice targeted 
overexpression of galanin by using rat PRL promoter 
shows that PRL mRNA levels were increased in female 
transgenic mice(14). These evidences convince us that 
galanin in the pituitary promotes the synthesis of PRL 
with the control of estrogen. On the somatotrophs, galanin 
progresses GH release under the induction of growth 
hormone-releasing hormone (GHRH) and its release 
is completely inhibited by somatostatin infusion(15). 
Pituitary GHRH receptor mRNA levels is increased by 
ovariectomy and decreased by estrogen. GH mRNA 
levels were unchanged by ovariectomy but decreased 
after estrogen treatment(16). Galanin is expressed in 
the mammalian anterior pituitary as mRNA(11,17-19) and 
protein(20). Therefore, galanin to somatorophs has an 
enhancing action of GH release.
 Immunohistochemistry on pituitary tissues shows that 
galanin and ACTH were coexpressed in the cytoplasm of 
the same adenoma cells in the corticotrophs(10). In this 
study, Crooke's cells and basophilic cells spreading to the 
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posterior lobe were positive for galanin. An intravenous 
bolus injection of galanin does not alter baseline and 
releasing hormone-stimulated secretions of PRL, TSH, 
LH, and FSH, but to reduce slightly in both the ACTH and 
cortisol in the stimulation of CRH(21,22). GAL is involved 
in a small partial inhibition of the preovulatory surges 
of LH without altering the FSH surge(23). Collectively, 
galanin aﬀects the reduced secretion of ACTH and the 
increased secretion of PRL and GH. In these interaction, 
no correlations exist between GAL and either GH or 
ACTH circadian proﬁles(24).
 Since the lack of rhythmicity in the circadian proﬁle 
of plasma GAL levels in healthy human subjects, 
physiologically circulating levels of GAL are likely not 
involved in the regulation of GH secretion(24). Locally 
produced galanin inhibits ACTH release by modulation 
of corticotropin release(25,26). Over-expression of galanin 
in the anterior pituitary using the rat GH promoter 
inﬂuences to promote the diﬀerentiation of lactotrophs 
and to increase PRL, GH, galanin but not TSH and LH in 
serum levels(27).  Since galanin and ACTH are coexpressed 
in the cytoplasm of the same adenoma cells, the 
interaction between galanin and proopiomelanocortin 
(POMC) may occur in the same cells. Both galanin and 
galanin mRNA are dramatically up-regulated in the 
anterior pituitary by estrogen, which is released at the 
early proestrus state(12,28). Proteolytic processing of 
POMC release ACTH and is mediated through either 
PC1 or PC2, when secretory granules become mature. 
Cathepsin L generates peptide intermediates with 
N-terminal basic residue extensions(29,30). The traﬃc 
of the processing and secretory granule formation is 
complicated in the same cells, but it is possible that the 
formation of galanin and ACTH granules are shared with 
the same secretory and transportable machine. As far 
as the corticotrophs, the inhibition of the preovulatory 
surges of LH by galanin may be included in the reduced 
secretion of ACTH.
 LH surge is responsible for initiating ovulation 
and results from an abrupt and massive increase in 
hypophyseal portal GnRH. Estrogen inﬂuences upon the 
GnRH neurons and pituitary gonadotrophs to generate 
the preovulatory LH surge. Although the surge of GnRH 
occurs between proestrus 1200 h and proestrus 1800 
h, the expression of galanin in the hypothalamus is 
constant in the state of proestrus 1200 h, proestrus 
1800 h, and estrus 1800 h in situ hybridization(31). A part 
of the galanin mRNA is located in the GnRH neurons and 
is the maximum peak of the galanin mRNA in the estrus 
state. The expression of galanin in the hypothalamus is 
not associated to GnRH surge but to basic level of GnRH, 
known as GnRH pulse generator.
 Many studies support that estrogen exerts a powerful 
stimulatory inﬂuence on GnRH secreted from nerve 
terminals in the median eminence to initiate the LH 
surge. However, it remains in both positive and negative 
feedback pathways whether estrogen acts directly 
to GnRH neurons in the hypothalamus or not(32). The 
interaction between galanin and LH surge in the pituitary 
remains unknown although galanin and galanin mRNA 
are dramatically up-regulated in the anterior pituitary by 
estrogen.
The endocrine galanin hypothesis
 We here hypothesis that the serum level of galanin 
determines the modulation of nociception and 
harmonizes the sensitivity to threshold of nociception 
in the peripheral nervous system. This hypothesis is 
deduced from the followings.
 The preprogalanin mRNA expression in the pituitary 
is enough amount of an endocrine hormone. Its 
corresponding amount of the galanin receptors are not 
present in the pituitary. If the galanin produced in the 
pituitary is an endocrine hormone, the galanin must play 
a role in the peripherals. The periodic rhythm of galanin 
is the exactly same as that of ovulation or LH surge 
because the expression of galanin is dramatically up-
regulated in the anterior pituitary by estrogen. If galanin 
harmonizes the sensitivity to threshold of nociception in 
the peripheral nervous system, the periodic rhythm of 
galanin requests to standardize the sensitivity by galanin 
periodically. 
 Plasma galanin levels in postmenopausal women are 
signiﬁcantly lower than in young women(33). Climacteric 
patients with nervousness have lower serum galanin 
concentration than patients without this symptom(34). 
Although the symptons of menopausal women include 
vasomotor symptoms, urogenital atrophy, osteoporosis, 
cardiovascular disease, cancer, psychiatric symptoms, 
cognitive decline, and sexual problems, vasomotor 
symptoms in the peripheral nervous system are 
independent of any signiﬁcant change in mood or anxiety 
symptoms of the central system on the therapies.
A role of neuropeptide Y and galanin in the pituitary
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 An infusion of galanin is a dose-dependent increase 
of galanin in the circulation and induces the release of 
GH and PRL, and cardiovascular eﬀects(35). This means 
the circulation of galanin is eﬀective to both the central 
nervous system and the peripheral nervous system.
 Galanin knockout mice reveal nociceptive deﬁcits 
following peripheral nerve injury(36). Galanin over-
expressing animals show that galanin is an inhibitory 
neuromodulator of spinal cord transmission(37). Galanin 
plays a signiﬁcant role of peripheral galanin in pain 
transmission. The galanin levels in the circulation 
modulate the neurotransmitter release of acetylcholine, 
serotonin, norepinephrine, and neuropeptides. The 
neuromodulation of galanin may cause by decreasing 
the sensitivity of neurotransmitters rather than by 
inhibiting the neurotransmitter actions.
 The serum level of galanin is largely inﬂuenced in the 
same events by individual diﬀerences, age, gender, and 
diseases. According to the hypothesis, the threshold of 
sensitivity in the neurotransmission is diversiﬁed by 
galanin levels, which presents to form the neuronal 
plasticity in the adaptation.
Interaction between neuropeptide Y and 
gonadotrophs in the anterior pituitary
 Neuropeptide Y (NPY) containing 36 amino acids is 
an abundant and widespread peptide in the mammalian 
nervous system which acts as a neurotransmitter(38). 
NPY is discovered in pituitary portal blood of rats. 
Since immunocytochemistry demonstrates that 
the endogenous NPY presents in gonadotrophs, 
somatotrophs, corticotrophs and some lactotrophs, but 
not in thyrotrophs, NPY was indicated to play a direct 
regulatory role in adenohypophyseal secretion(39). In 
fact, the concentration of NPY immunoreactivity in 
portal plasma (52.0 ± 4.0 ng/ml, mean ± SEM) was 
three times greater (p < 0.005) than in systemic plasma 
(16 ± 4.5 ng/ml)(40). Both intravenous (300μg) or 
intraventricular (2 to 15μg) injection of NPY provide 
a signiﬁcant and long-lasting decrease of plasma LH 
levels in gonadectomized male rats(41). NPY produces 
no signiﬁcant change in release of pituitary hormones 
in anterior pituitary cells in culture(41). These mean 
that NPY is released into the hypophyseal portal blood 
for transportation to the anterior pituitary where it 
enhances the release of LH in response to GnRH. Finally, 
the function of NPY in the pituitary involves an allosteric 
increase in GnRH binding to its receptor leading to 
augmented inﬂux of Ca2+ from the extracellular space. 
NPY plays a critical role in stimulating the basal pattern 
of luteinizing hormone (LH) release as well as the 
preovulatory surge of LH release in several species. 
The stimulatory eﬀect of NPY on LH secretion is 
dependent upon the presence of gonadal hormones(42). 
Genetic modiﬁcation also supports the stimulation of 
LH secretion by NPY. NPY knockout mice show the 
attenuation of LH surges(43).
Conclusion
 We propose the hypothesis that galanin produced 
mainly in the pituitary determines the modulation of 
nociception as an endocrine hormone and harmonizes 
the sensitivity to threshold of nociception in the 
peripheral nervous system.
 The key neuroendocrine signals for stimulation of 
gonadotropin surges have been known for many decades, 
and the cellular mechanisms that integrate these signals 
have been studying. In this review, we focused on the 
interaction between LH release and its related peptides 
in the pituitary tissue. NPY plays an important role of 
enhancing LH release in the proestrus LH surge at the 
pituitary portal vessels. The interaction between NPY 
and GnRH on GnRH receptors will provide a potential 
target for the treatment of ovulatory disorders.
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